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ABSTRACT 
Background:  The prevention of initiation of tobacco, alcohol and drug use is a major societal 
challenge, for which the existing research literature is generally disappointing. This study 
aimed to test the effectiveness of adaptation of Motivational Interviewing (MI) for universal 
prevention purposes, i.e. to prevent initiation of new substance use among non-users, and to 
reduce risks among existing users.  
Methods: Cluster randomised trial with 416 students aged 16-19 years old recruited in 12 
London Further Education colleges without regard to substance use status. Individualised MI 
was compared with standard practice classroom-delivered Drug Awareness intervention, both 
delivered over the course of one lesson. Prevalence, initiation and cessation rates for the 3 
target behaviours of cigarette smoking, alcohol consumption and cannabis use, along with 
reductions in use and harm indicators after both 3 and 12 months were assessed. 
Results: This adaptation of MI was not demonstrated to be effective in either intention-to-
treat or sub-group analyses for any outcome. Unexpected lower levels of cannabis initiation 
and prevalence were found in the Drug Awareness control condition. 
Conclusions: This particular adaptation of MI is ineffective as a universal drug prevention 
intervention and does not merit further study.  
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1. INTRODUCTION 
The use of mood altering substances constitutes a risk factor for a range of possible direct 
harms to individual health and well-being, and particularly among children and young people, 
there is also the risk of escalation from lower to higher levels of risk (Institute of Medicine, 
1996).  Given the intractable nature of drug dependence, the associated public health burden 
and wider societal costs, effective methods of prevention of tobacco, alcohol and other drug 
use, particularly amongst the young, are likely also to be highly cost-effective (Caulkins et al. 
2004).  
 
The evidence-base on the effectiveness of interventions undertaken to prevent tobacco, 
alcohol and other drug use is disappointing. The vast majority of interventions with children 
and young people are delivered in schools. Two Cochrane systematic reviews covered the 
prevention of both tobacco and illicit drug use in schools, and included 94 (Thomas & Perera, 
2006) and 29 trials (Faggiano et al. 2005) respectively, whilst a review of interventions for 
drug prevention in all settings other than schools included 17 trials (Gates et al. 2006).  
Seventy-five per cent (42 of 56) of studies included in the Cochrane review of the prevention 
of alcohol misuse were undertaken in schools (Foxcroft et al. 2002).  Across these reviews, 
some interventions appear to exert short-term effects, whilst others appear to be ineffective. 
There is little high quality evidence that any interventions in schools can have any long-term 
effects, and the weakness of this evidence-base and the need for more research are common 
conclusions in these reviews. 
 
In contrast, there is good evidence for Motivational Interviewing (MI; Miller & Rollnick, 
2002), particularly so in relation to alcohol problems (Hettema et al., 2005).  Adaptations of 
MI have promising potential for risk reduction among young people across a range of 
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different behaviours (see Johnston et al. 2002 for example). Baer and colleagues (2001) 
identified effects to endure for at least 4 years in a trial among university students, and 
specified the acceleration of maturational trends as a likely mechanism of effect. As far as we 
are aware, the existing evidence-base for MI in relation to substance misuse is entirely 
comprised of interventions with those who have already initiated the use of particular 
substances, with the exception of a small pilot trial (which included 4 non-drinkers in a 
sample of 34) evaluating a group intervention informed by MI (Bailey et al. 2004). It is 
unknown whether MI may be useful for universal prevention purposes and thus may be 
adapted to effectively prevent initiation of substance use. 
 
2. METHOD 
This study was undertaken as an exploratory trial in order to prepare for a later larger 
definitive trial designed to influence resource allocation decisions (Medical Research 
Council, 2000). A cluster randomised trial design was chosen to compare the possible 
effectiveness of MI against standard practice in the educational setting. Clusters comprised 
whole class groups of students. This comparison involved investigation of the potential 
impact of intervention in groups with heterogeneous risk characteristics, yet who provide a 
common targeting opportunity. The overarching hypothesis tested was that MI would reduce 
drug use and related risk in comparison to the standard practice group intervention, after both 
three and twelve months, with target drug use for the interventions being cigarette smoking, 
alcohol consumption and cannabis use. Both primary prevention effects (i.e. relating to 
initiation of use of drugs) and secondary prevention effects (i.e. among those who were 
already using particular substances) were sought. Ethical approval was given by the Institute 
of Psychiatry, King’s College London.  
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2.1. Setting & Participants 
Further Education (F.E.) Colleges in Britain are non-traditional educational and training 
institutions catering to large numbers of older teenage students. There is usually one F.E. 
college in each London borough (the local government administrative unit). As in a previous 
study (McCambridge & Strang, 2004), we approached all colleges within a defined 
geographical limit and negotiated study participation. The response was encouraging with 12 
out of 21 colleges approached agreeing to participate.  Age 16-19 years old was adopted as 
the sole inclusion criterion, and there were no formal exclusion criteria. No attention was thus 
paid to the prior drug use status of participants in their recruitment to the study. Student 
groups were specifically targeted that comprised wholly or mainly those who had not 
completed Level 2 education (defined as having at least 5 General Certificate in Secondary 
Education [GCSE] grades A – C or equivalent) i.e. those who had not achieved the 
conventional measure of educational attainment on completion of compulsory schooling in 
Britain. 
 
2.2.Interventions 
Motivational Interviewing (MI) is a highly individualised intervention (Miller & Rollnick, 
2002).  Its aim is to help the participant explore their own behaviour. Particular emphasis is 
given to perceptions of risk and problem recognition, concerns and consideration of change, 
and also to the activity of the practitioner in directing attention towards the resolution of 
ambivalence. We previously developed an intervention model for which impressive evidence 
of short-term secondary prevention benefit had been obtained among older teenage cannabis 
smokers, including impact on drinking and cigarette smoking (McCambridge & Strang, 2004; 
2005).   We adapted our previous intervention model (McCambridge & Strang, 2003) for this 
study by designing new topic material specifically for primary prevention purposes. For 
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example, participants were encouraged to think through and discuss a series of hypothetical 
situations in which they might find it difficult to refuse offers of drugs they had not 
previously used. We also explored the reasons for not using specific substances, and how 
initiation of use might affect future plans. The basic topic structure from the previous version 
was thus retained (McCambridge & Strang, 2003).   
 
Drug education is not mandatory in F.E. colleges and there is considerable diversity in 
activity levels with little evaluation (Slym et al., 2007).  As a consequence, we standardised a 
“Drug Awareness” (DA) control intervention on the basis of usual practice as described by 
college-based practitioners. This comprised a 16-question quiz on the effects of cigarette 
smoking, alcohol consumption and cannabis use, followed by further discussion components 
and the provision of leaflets giving accurate information on the effects of target drugs.  The 
harm reduction orientation of this intervention reflected the standard approach in Britain. 
Absent from this DA control intervention were the opportunity to discuss personalised risks 
or concerns, and also practitioner behaviour designed to heighten awareness of individualised 
risk, elements considered to be fundamental to MI.   
 
Both interventions were scheduled for delivery during a one-hour lesson. We agreed with the 
colleges that students who were older than our target age range would not be withdrawn from 
classes, resulting in delivery of DA to non-study participants. In addition to 2 researchers, 6 
college-based practitioners were invited for workshop-based training in the delivery of both 
interventions and subsequently participated in the study. The majority of the interventions in 
both study conditions were actually delivered by the 2 researchers (n=144 and n=109 
respectively). We aimed to audio-record a random sample of 1/4 MI sessions for fidelity 
monitoring purposes within the context of ongoing supervision, though there were difficulties 
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in persuading college practitioners to adhere to this target, resulting in a total of 31 MI 
sessions of 159 actually delivered being audio-recorded. This shortfall of 9 sessions was 
mostly due to some college practitioners being either uncomfortable asking participants for 
this to be done or about having their own practice sessions audio-recorded. There were 4 
instances of problems with the equipment or its use among college practitioners, for whom 
participation in supervision sessions with the two researchers was less than had been hoped. 
The two researchers were in turn supervised by the first author.  
 
2.3.Outcomes and Data Collection  
The extent of initiation among non-users of particular substances provided a simple measure 
of primary prevention outcome. In line with the previously conducted study, reduced 
consumption was used as a proxy measure of beneficial change among those already using a 
particular substance (McCambridge & Strang, 2004).  In addition to measures of use assessed 
over the past month we included measures of risk and harm for each substance as follows; 
nicotine dependence was measured with the Fagerstrom scale (Heatherton et al. 1991); 
cannabis dependence with the Severity of Dependence Scale (SDS; Gossop et al. 1995); and 
hazardous drinking with the Alcohol Use Disorder Identification Test (AUDIT; Babor et al. 
2001); and a measure of interactional problems for each substance which counts the number 
of relationship problems that the young person themselves attributes to their own use 
(McCambridge & Strang, 2004). The AUDIT was the sole exception to the one month 
timeframe, where we reduced the reference period from the usual past year to be past three 
months in line with the needs of follow-up study. Assessments instruments were designed to 
be brief in accordance with the preferences of the colleges. 
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Study participants self-completed questionnaires at baseline and at both follow-up intervals 
after 3 and 12 months, either in classrooms (for the bulk of the first follow-up assessments) or 
in individually scheduled appointments (for all of the second follow-up assessments) as 
necessary. Contacts were initially made by telephone to schedule individual appointments. 
The researcher involved in the administration of the follow-up data collection at any college 
had not been involved in the delivery of interventions in that college, though was not always 
blind to study allocation.     
 
2.4.  Sample Size  
The novelty of this study posed difficulties for sample size estimation. We based our power 
calculations on our previous secondary prevention work.  One hundred and forty subjects per 
group were required to detect a consumption effect size of 0.40 after three months. This 
estimate was similar to the lowest effect size previously obtained for secondary prevention 
after 3 months (0.34 [0.1-0.6] for cigarette smoking), though is modest in comparison with 
the largest effect size previously obtained (0.75 [0.45-1.0] for cannabis use in McCambridge 
& Strang, 2004).  This assumed a within-cluster variance of 0.9 and an intra-class correlation 
coefficient of 0.01(from the previous trial) and guaranteed 80% power at the 5% significance 
level. We also assumed that two thirds of all study participants would be users of each of the 
three target drugs requiring a total study population of 420. These assumptions used in the 
power calculation proved to be inaccurate (see Results).  
 
2.5. Randomisation 
Computerised randomisation was undertaken by the local Clinical Trials Unit and decisions 
were communicated by telephone to researchers after recruitment and baseline data collection 
on an individual college basis to preserve allocation concealment. We stratified allocation by 
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college, so that equivalent numbers of groups recruited from any one college would be 
allocated to each study condition. 
 
2.6. Statistical methods 
Two sets of analyses were undertaken. Firstly, an ‘intention-to-treat’ analysis considered the 
entire study population as it has been randomised, with last observations carried forward to 
deal with missing data. Secondly, there was an a priori decision to consider outcomes in sub-
groups formed by drug use status at study entry, so that, for example, cigarette smoking 
outcomes were evaluated among those who were or were not cigarette smokers at baseline. 
No statistical corrections for multiple testing have been used, instead individual outcomes 
were interpreted in the context of their coherence with the outcome dataset in general.   
 
It was deemed preferable to adopt a straightforward and consistent approach to analysis in 
light of the number of outcomes being evaluated. The binary outcomes of prevalence, 
cessation and initiation were modelled with logistic regression and all other outcomes 
presented in the tables were continuous and modelled in multiple regressions. As many of the 
continuous data violated assumptions of normality, change scores were created as outcome 
variables which reduced this problem in the multiple regression models. For both logistic and 
multiple regressions, the outcome model incorporated a practitioner grouping variable, 
dummy coded to have the 3 practitioner groups (each researcher plus all college practitioners 
combined) and a fourth category consisting of non-attenders. Logistic regression models also 
included the baseline measure of the outcome variable.  Analyses were undertaken using 
STATA Version 9 software. The Huber/White Sandwich estimator of variance was used to 
control for the effects of cluster allocation in the whole class groups which had been 
randomised (with the STATA command “cluster”).    
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 ***Insert Table 1 about here*** 
 
3. RESULTS 
Randomisation successfully created baseline equivalence between groups – see Table 1. 
Other drug use was rare; only 5% (20/416) reported ever having used any other drug, with 
ecstasy being the most common other drug, previously used by 4% (17/416), followed by 
cocaine and amyl nitrate (2%, 8/416 for both). After 3 months, the MI group were followed 
up slightly earlier than the Drug Awareness (DA) group (96.9 days [SD 17.3] compared to 
102.6 days [18.6], t= 3.15, p=0.0017). This mean difference had reduced to 2.3 days at 12 
month follow-up, which was no longer statistically significant (t=0.78, p=0.436). There were 
no refusals to participate and follow-up rates were satisfactory (89% after 3 months [371/416] 
and 84% [348/416] after 12 months). The flowchart of participants through the trial is 
presented in Figure 1.  
 
***Insert Figure 1 about here*** 
 
Attrition was not differential between the study groups (3 months 12% [25/206] MI, 10% 
[20/210] DA, χ2 [1]=0.74, p=0.391; 12 months 18% [37/206] MI, 15% [31/210] DA, χ2 
[1]=0.78, p=0.378) but was not random in a number of other important respects. Older study 
participants were more likely to be lost to follow-up at both intervals (3 and 12 months 
followed-up 17.5 years mean age compared to 17.9 years lost to follow-up at 3 months, 
t=2.79, p=0.006, and 17.8 years lost to follow-up at 12 months, t=2.48, p=0.014);  as were 
males at both intervals (3 months 14% [32/223] male, 7% [13/193] female, χ2 [1]=6.22, 
p=0.013; 12 months 20% [44/223] male, 12% [24/193] female, χ2 [1]=4.03, p=0.045); those 
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categorized as mixed race or other at 3 months (24% [9/38] compared to White, Black and 
Asian groups, χ2 [3]=8.26, p=0.041); those who had ever sold drugs to friends at both 
intervals (3 months 29% [6/21] sold drugs, 10% [39/392] not sold drugs, χ2 [1]=7.12, 
p=0.008; 12 months 33% [7/21] sold drugs, 16% [61/392] not sold drugs, χ2 [1]=4.58, 
p=0.032); cigarette smokers at 3 months (19% [22/117] smokers, 8% [23/299] non-smokers, 
χ2 [1]=10.76, p=0.001); and cannabis smokers at both intervals (3 months 21% [19/90] 
smokers, 8% [29/326] non-smokers, χ2 [1]=12.61, p<0.001; 12 months 24% [22/90] smokers, 
14% [46/326] non-smokers, χ2 [1]=5.51, p=0.019). 
 
3.6.Main Outcomes 
There were no statistically significant between-group differences in intention-to-treat 
analyses for either cigarette smoking or alcohol consumption outcomes. There were also no 
statistically significant between-group differences when the analyses were restricted to those 
who were already users of these substances upon entry to the study. Outcome data for 
cigarette smoking are presented in Table 2 and for alcohol consumption in Table 3. 
 
***Insert Table 2 about here*** 
 
***Insert Table 3 about here*** 
 
Cannabis use prevalence was lower in the control group at both 3 and 12 months – see Table 
4. There was also less initiation of cannabis use in the control group over the 12 month study 
period as a whole, though the numbers involved are small (MI 14 initiators, DA 4 initiators). 
There were no other statistically significant between-group differences in intention-to-treat 
analyses nor when the analyses were restricted to those who were or were not already using 
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cannabis upon entry to the study, though there is a general trend towards better outcomes in 
the control group (see Table 4).  
 
***Insert Table 4 about here*** 
 
3.7.Further Analyses 
Non-attendance at interventions made little difference to observed outcomes. Non-attenders 
were distinct only in relation to the following outcomes; they had not reduced their frequency 
of cigarette smoking after 3 months (mean change score 0.48 compared to -5.6 in the 
reference category of the practitioner delivering most interventions; difference adjusted for 
intervention 6.58 [1.67-11.49], p=0.013); similarly they had not reduced the number of 
cigarettes smoked per day at 3 months (mean change score 0.52 compared to -1.2; adjusted 
difference 2.15 [0.15-4.15], p=0.037); 91% (41/45) of baseline drinkers who did not attend 
were still drinking after 3 months compared to 77% in the reference group (54/70; OR=3.0 
[1.18-7.62], p=0.021); mean AUDIT scores had also not reduced at this same interval 
(change score 0.47 compared to -2.1; adjusted difference 2.57 [0.90-4.24], p=0.006). There 
were no differences whatsoever in outcome after 12 months between those who had attended 
interventions and those who had not.  
 
There were differences in outcome apparent between the 3 practitioner groupings. These 
were most pronounced between the two researcher practitioners, and those which are 
statistically significant are presented in Table 5. Further analyses revealed no practitioner-
intervention interactions in outcomes for these two. Outcomes for the college practitioner 
group were distinct from the reference practitioner only in the following cases; 61% (11/18) 
of baseline cigarette smokers were still smoking after 12 months compared to 83% (34/41) 
12 
 
for the reference practitioner (OR=0.36 [0.13-1.00], p=0.05); 88% (28/32) of baseline 
drinkers were still drinking after 3 months compared to 77% (54/70) in the reference group 
(OR=2.23 [1.23-4.02], p=0.008); 16% (9/57) of non-smokers at study entry initiated cigarette 
smoking over the 12 month study period, compared to 7% (7/103) in the reference group 
(OR=2.57 [1.01-6.58], p=0.049);  and 21% (9/43) of non-drinkers initiated drinking during 
the 12 month study period, compared to 11% (8/74) in the reference group (OR=2.24 [1.21-
4.18], p=0.01).  
 
***Insert Table 5 about here*** 
 
A series of paired t-tests was undertaken to consider whether there was statistically 
significant change over time in the sub-group of baseline users of each drug regardless of 
study allocation. The mean number of cigarette smoking days reduced from 21.7(10.7) to 
18.3 days (12.9) after 3 months (t=3.46, p=0.0008), and this mean reduction was maintained 
at 17.4 days (13.1) after 12 months (t=3.68, p=0.0004). The mean number of cigarettes 
smoked per day reduced from 6.6 (5.6) at study entry to 5.9 (5.9) after 3 months (t=1.97, 
p=0.0508) and to 5.6 cigarettes (5.8) after 12 months (t=2.17, p=0.0325). Mean frequency of 
drinking reduced from 4.4 days (6.0) to 3.7 days (5.3) in the first 3 months (t=2.34, p=0.02), 
though this reduction was not maintained. Mean AUDIT scores reduced in the first 3 months 
from 6.7 (SD 5.5) to 5.7 (5.9; t=3.45, p=0.0007) and remained reduced (5.4 [5.7] at the 
twelve month interval (t=3.21, p=0.0016). The mean monthly frequency of cannabis use 
reduced from 16.3 days (12.1) to 13.6 days (12.6) after 3 months (t=3.36, p=0.0012), and to 
12.1 days (14.7) after 12 months (t=2.89, p=0.0049). Similarly the mean number of joints 
smoked in the previous week reduced from 10.0 (11.4) to 8.0 (10.3) after 3 months (t=3.06, 
p=0.0031), and to 6.2 (9.0) after 12 months (t=3.63, p=0.0005). Otherwise cigarette smoking, 
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alcohol consumption and cannabis use were unchanged over time among those who were 
using these substances at study entry. 
 
4. DISCUSSION 
No evidence supporting the use of MI for universal prevention has been obtained. This 
includes a lack of effect on reduced initiation of substance use, and there is also an absence of 
secondary prevention effects, as would be expected on the basis of prior studies, particularly 
on alcohol consumption (Baer et al. 2001; McCambridge & Strang, 2004; Hettema et al. 
2005; Gray et al., 2005).  What between-group differences there are suggest the possible 
effectiveness of the classroom-based Drug Awareness discussion on the prevalence of 
cannabis use. We view this to be very unlikely in light of the current state of the prevention 
literature, in which the most promising interventions are much more intensive and/or multi-
modal (e.g. Faggiano et al. 2010).  
 
Application of formal MI fidelity measures was not possible due to the novel nature of this 
adaptation. There are no existing validated MI fidelity measures currently available which 
might be used for the purposes of assessing fidelity in adaptations of MI with behaviours not 
engaged in by the participants. Although we could have used such measures in relation to 
current behaviours at study entry, existing measures also require the identification of a single 
target behaviour, making their use problematic in the multiple behaviour targeting context of 
this study. We developed and used a simpler instrument, which provided some data on the 
conduct of the discussion, which was unrelated to outcome (data not reported). These data do 
not, however, permit any valid assessment of the extent to which the intervention 
implemented can be accurately described as high quality MI which would not have been 
possible for reasons previously given. By virtue of the nature of the control intervention, we 
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can be confident that the structural components (i.e. the quiz questions) were delivered, 
though we cannot exclude the possibility that subsequent discussions were handled in ways 
influenced by MI. The absence of MI fidelity study is an important barrier to making 
inferences from this study generalisable to the possible effects of MI for such purposes more 
broadly.   
 
 The practitioner differences detected give rise to concern that high-quality MI was not 
consistently delivered, and importantly, that it was not straightforward to do so with this 
adaptation. Audio-recordings and supervision discussions suggested that although there was 
good adherence to the structure of the intervention, the sessions could not be strongly 
characterised as embodying the spirit of MI. Although interventions were delivered in a 
person-centred way, they were not consistently successful in elaborating the participants 
thoughts about behaviours with which they were not involved. The basic concept was that it 
would be possible to have the participant consider the possibility of engaging in these 
behaviours and then for them to describe discrepancy with important values and goals.  As 
this was not consistently achieved, despite some promising pre-trial developmental work, this 
suggests an obvious limitation to the value of this approach. These individual discussions 
were nevertheless clearly distinct from the main content of the control condition where the 
focus was on the provision of information in groups. 
 
Although baseline data were included in outcome models, there was also no random 
allocation of practitioners to colleges. It is interesting that there is variability across 
substances in these practitioner differences with Practitioner 1 achieving better outcomes for 
alcohol consumption and cannabis use and Practitioner 2 being more successful for cigarette 
smoking. It has also been known for some time that these types of practitioner effects on 
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achieved outcomes both exist across different types of counselling interventions and are also 
variable across outcomes (Luborsky et al. 1985).  It will be preferable to monitor adherence 
more formally in future studies of MI adaptations, adapting existing process instruments if 
necessary, and also studying carefully the content of interventions delivery with multiple 
behavioural targets. The outcome dataset has a complex multi-level structure and perhaps we 
could have explored it more fully with more sophisticated models. We preferred to keep the 
analyses as simple as possible in light of this complexity and the null findings suggested clear 
limits to the value of further data analyses.  
 
There are other study limitations to be borne in mind. We were less successful than we had 
hoped in recruiting and retaining college-based practitioners in the study following the offer 
of training, and dedicated remuneration and protected time to deliver study commitments will 
be appropriate for further studies in this setting. Outcome data evaluated here have been 
entirely self-reported. Prevalence levels at study entry are broadly in line with what might be 
expected, taking account of existing survey data (Goddard & Green, 2005; Fuller 2005).  
However, the nature of change over time among relatively small sub-samples requires 
examination. It would appear that the monthly rate of cannabis initiation was approximately 9 
times higher during the first 3 month study period (11 cases MI, 3 cases DA), than in the 
subsequent 9 month period (3 cases MI, 1 case DA). Some participants may be more likely to 
honestly report drug use subsequently if they have received MI.  It will be important to be 
vigilant about this possibility in future studies of MI. 
      
Is there an effect favouring DA on cannabis prevalence here, notwithstanding the above 
caveats? Variable impact across substances is indeed plausible, and there was greater 
statistical power to detect an effect on cannabis initiation. It is unclear, however, why such an 
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effect might occur specifically on the use of this substance and not on others. In addition to 
what is known about the intensive and multi-modal nature of effective drug prevention (e.g. 
Faggiano et al. 2010), this possibility is not supported by the most recent review of MI 
effectiveness by Lundahl and colleagues (2010). They found MI effects on cannabis use to be 
as large if not larger than those for tobacco and alcohol in studies with strong comparison 
groups. If interventions such as DA really do have these effects, then their lack of prior study 
may be responsible for this appearing so surprising. We do not, however, view this as a 
promising line of enquiry. The change over time data suggest the possibility of both 
interventions having equivalent effects, or indeed of study participation itself exerting a 
positive influence, although the paucity of differences between attenders and non-attenders 
suggests the opposite. In any case, inferences of effects in trials should be reserved for 
differences between study conditions, rather than across them.   
 
We believe it is more likely that neither intervention has been effective in changing the 
behaviour of the study participants, and if this is proven to be correct, there is an important 
implication to be considered: Combining pursuit of primary and secondary prevention effects 
has apparently served to blunt the impact upon existing substance use that should be expected 
on the basis of previous secondary prevention studies, most notably upon alcohol 
consumption, for which there is the largest and most positive evidence-base (Baer et al. 2001; 
Hettema et al. 2005; Gray et al., 2005).   It seems likely that in trying to prevent young people 
from doing something which they are not, we have unfortunately hampered the possibility of 
healthy influence of their current behaviour.  
 
Consideration of the nature of the study population and setting is important to evaluation of 
the generalisability of these findings. Further Education colleges attract diverse students. We 
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specifically targeted for inclusion those who had not achieved the basic standard in 
compulsory schooling to age 16. Our study population is thus best characterised as 
comprising those who have failed in, or been failed by, the school system and who 
nevertheless make further attempts to acquire education and skills training.  This population 
may not be as receptive to intervention as other groups of young people for a multitude of 
reasons to do with heightened risk and vulnerability. Our age group is also older than that 
commonly targeted for drug prevention purposes.   
 
This is a single study of a novel adaptation of MI to a fundamentally different type of target: - 
prevention of initiation of a new behaviour. Inference of ineffectiveness of MI should be 
restricted to this particular model of adaptation of MI, and to this specific population, who are 
appreciably older than many other populations targeted for universal drug prevention, and for 
whom lack of success in conventional education may be a marker of wider resistance to 
intervention. It remains possible that a discussion in the spirit of MI could focus upon 
resilience rather than risk factors and effectively deter initiation of drug use. To explore this 
possibility requires further developmental work adapting MI for this purpose.  It may, 
however, be the case that actual involvement in substance use (and perhaps also experience 
of heightened risk or harm) is necessary for MI to exert influence on behaviour. Future work 
should consider carefully the age tailoring and the detailed content of MI for both universal 
and more targeted applications. Rethinking prevention to encompass a lack of direct focus on 
individual behaviour may provide further possibilities for study (Bonell et al., 2007; Newbery 
et al., 2007). 
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Figure 1: Participant Flowchart 
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